Showing results (81-90 of 121) with videos related to
Sort By:
Pageof 13
Bone|June 17, 1998
Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of ageJ L Ferretti, R F Capozza, G R Cointry, et al.The Journal of Clinical Endocrinology and Metabolism|November 14, 2014
Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosisBenjamin Z Leder, Louis St L O'Dea, José R Zanchetta, et al.The Journal of Clinical Endocrinology and Metabolism|June 17, 2011
Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluationG Reato, L Morlin, S Chen, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's diseaseC Betterle, M Volpato, B Rees Smith, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 16, 2016
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With OsteoporosisRoger Zebaze, Cesar Libanati, Michael R McClung, et al.Acta Diabetologica|July 1, 1996
An immunological and genetic study of patients with gestational diabetes mellitusA Lapolla, C Betterle, M Sanzari, et al.Hormone Research|January 1, 1991
Long-term low-dose glucocorticoid therapy in hyperandrogenized women: utility and effects on bone mineral content and hypothalamic-pituitary-adrenocortical functionL N Contreras, L Rizzo, R M Gómez, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trialStuart L Silverman, Claus Christiansen, Harry K Genant, et al.Cytokine|June 28, 2005
Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newbornA Lapolla, M G Dalfrà, M Sanzari, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 10, 2006
Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysisM C Nevitt, P Chen, D P Kiel, et al.Pageof 13